ABBV
AbbVie Inc.
Latest News for ABBV
Many of you are probably options traders. Several of our analysts at TheStreet Pro are, and when times are risky, they will often suggest options a......
Abbvie ($ABBV) announced an update on their ongoing clinical study. The AbbVie (ABBV) study “Observational Prospective Study to Evaluate Effectiven......
Abbvie ($ABBV) announced an update on their ongoing clinical study. The AbbVie (ABBV) study “Observational Prospective Study to Evaluate Effectiven......
Scotiabank analyst Louise Chen maintained a Buy rating on AbbVie today and set a price target of $280.00. According to TipRanks, Chen is a 4-star a......
Analysts fell to the sidelines weighing in on AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF) and Hims & Hers Health (HIMS) with neutral ratings, i......
Analysts fell to the sidelines weighing in on AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF) and Hims & Hers Health (HIMS) with neutral ratings, i......
Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has completed a real world study called “Prospective Observationa......
The Schwab U.S. Dividend Equity ETF ($SCHD) has been one of the strongest performers of 2026, outgaining the S&P 500 ($SPX) by over 12% so far this......
AbbVie ( ($ABBV) ) has fallen by -7.40%. Read on to learn why. AbbVie shares fell 7.40% over the past week, even as Wall Street analysts largely st......
Abbvie ($ABBV) announced an update on their ongoing clinical study. The phase 1 study, officially titled “A Phase 1 Study in Healthy Subjects to As......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 12 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABBV | $211.59 | 0% | 4.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |